BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6572976)

  • 1. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence.
    Kanwar YS; Rosenzweig LJ; Linker A; Jakubowski ML
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2272-5. PubMed ID: 6572976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthetic regulation of proteoglycans by aldohexoses and ATP.
    Kanwar Y; Yoshinaga Y; Liu Z; Wallner E; Carone F
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8621-5. PubMed ID: 1528871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo cellular synthesis of sulfated proteoglycans of the developing renal glomerulus in vivo.
    Kanwar YS; Jakubowski ML; Rosenzweig LJ; Gibbons JT
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7108-11. PubMed ID: 6239287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of de novo synthesized sulfated glycosaminoglycans in the glomerular basement membrane and mesangial matrix.
    Kanwar YS; Rosenzweig LJ; Jakubowski ML
    Lab Invest; 1983 Aug; 49(2):216-25. PubMed ID: 6410121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species.
    Kashihara N; Watanabe Y; Makino H; Wallner EI; Kanwar YS
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6309-13. PubMed ID: 1631123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
    Templeton DM
    Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in glomerular proteoglycan metabolism in experimental non-insulin dependent diabetes mellitus.
    Fioretto P; Keane WF; Kasiske BL; O'Donnell MP; Klein DJ
    J Am Soc Nephrol; 1993 Apr; 3(10):1694-704. PubMed ID: 8318686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes.
    Cohen MP; Surma ML
    J Lab Clin Med; 1981 Nov; 98(5):715-22. PubMed ID: 7028893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
    Gambaro G; Venturini AP; Noonan DM; Fries W; Re G; Garbisa S; Milanesi C; Pesarini A; Borsatti A; Marchi E
    Kidney Int; 1994 Sep; 46(3):797-806. PubMed ID: 7527876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hypophysectomy on renal proteoglycans and their modulation by insulin-like growth factor-I and its receptor.
    Watanabe Y; Liu ZZ; Kumar A; Wallner EI; Kashihara N; Kanwar YS
    Endocrinology; 1994 Jan; 134(1):358-70. PubMed ID: 8275951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased microalbuminuria in diabetic rats is independent of angiotensin II or glomerular proteoglycan synthesis.
    Whiteside C; Templeton DM
    Can J Physiol Pharmacol; 1992 Aug; 70(8):1096-103. PubMed ID: 1473041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteoglycans and glycosaminoglycans synthesized in vitro by mesangial cells from normal and diabetic rats.
    Hadad SJ; Michelacci YM; Schor N
    Biochim Biophys Acta; 1996 May; 1290(1):18-28. PubMed ID: 8645702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta-D-xyloside on the glomerular proteoglycans. I. Biochemical studies.
    Kanwar YS; Hascall VC; Jakubowski ML; Gibbons JT
    J Cell Biol; 1984 Aug; 99(2):715-22. PubMed ID: 6746744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
    van Det NF; van den Born J; Tamsma JT; Verhagen NA; van den Heuvel LP; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):759-68. PubMed ID: 7537959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diabetes on in vivo metabolism of [35S]-labeled glomerular basement membrane.
    Cohen MP; Surma ML
    Diabetes; 1984 Jan; 33(1):8-12. PubMed ID: 6690347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
    Cohen MP; Klepser H; Wu VY
    Diabetes; 1988 Oct; 37(10):1324-7. PubMed ID: 2970980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady state measurement of glomerular proteoglycan synthesis in streptozotocin-induced diabetes.
    Warren J; Mason RM
    Biochem Soc Trans; 1992 May; 20(2):97S. PubMed ID: 1397662
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-1-induced alterations in glomerular proteoglycans: biochemical and tissue autoradiographic aspects.
    Kashihara N; Watanabe Y; Makino H; Kanwar YS
    J Am Soc Nephrol; 1992 Aug; 3(2):203-13. PubMed ID: 1391721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-D-xyloside on the renal glomerular cells. II. Morphological studies.
    Kanwar YS; Rosenzweig LJ; Jakubowski ML
    Lab Invest; 1987 Feb; 56(2):160-9. PubMed ID: 3807315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal glomerular proteoglycans. An investigation of their synthesis in vivo using a technique for fixation in situ.
    Beavan LA; Davies M; Mason RM
    Biochem J; 1988 Apr; 251(2):411-8. PubMed ID: 3401215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.